NO985807L - Transdermal systems containing 2 active ingredients in separate sections, their preparation process and their use as a drug - Google Patents

Transdermal systems containing 2 active ingredients in separate sections, their preparation process and their use as a drug

Info

Publication number
NO985807L
NO985807L NO985807A NO985807A NO985807L NO 985807 L NO985807 L NO 985807L NO 985807 A NO985807 A NO 985807A NO 985807 A NO985807 A NO 985807A NO 985807 L NO985807 L NO 985807L
Authority
NO
Norway
Prior art keywords
drug
active ingredients
preparation process
systems containing
separate sections
Prior art date
Application number
NO985807A
Other languages
Norwegian (no)
Other versions
NO320999B1 (en
NO985807D0 (en
Inventor
Jean-Luc Dubois
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of NO985807D0 publication Critical patent/NO985807D0/en
Publication of NO985807L publication Critical patent/NO985807L/en
Publication of NO320999B1 publication Critical patent/NO320999B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
NO19985807A 1996-06-11 1998-12-11 Device for transdermal administration of 2 active ingredients in separate sections and its manufacturing process. NO320999B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607209A FR2749514B1 (en) 1996-06-11 1996-06-11 TRANSDERMAL SYSTEMS CONTAINING 2 ACTIVE INGREDIENTS IN SEPARATE COMPARTMENTS, THEIR PREPARATION METHOD AND THEIR APPLICATION AS A MEDICAMENT
PCT/FR1997/001024 WO1997047305A1 (en) 1996-06-11 1997-06-10 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine

Publications (3)

Publication Number Publication Date
NO985807D0 NO985807D0 (en) 1998-12-11
NO985807L true NO985807L (en) 1999-02-10
NO320999B1 NO320999B1 (en) 2006-02-27

Family

ID=9492920

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985807A NO320999B1 (en) 1996-06-11 1998-12-11 Device for transdermal administration of 2 active ingredients in separate sections and its manufacturing process.

Country Status (19)

Country Link
EP (1) EP0904086B1 (en)
JP (1) JP2000511921A (en)
CN (1) CN1119150C (en)
AR (1) AR008229A1 (en)
AT (1) ATE284215T1 (en)
AU (1) AU739141B2 (en)
BR (1) BR9715082A (en)
CA (1) CA2257913A1 (en)
CZ (1) CZ295350B6 (en)
DE (1) DE69731883T2 (en)
ES (1) ES2235236T3 (en)
FR (1) FR2749514B1 (en)
NO (1) NO320999B1 (en)
PL (1) PL189361B1 (en)
RU (1) RU2209090C2 (en)
TR (1) TR199802577T2 (en)
TW (1) TWI228999B (en)
WO (1) WO1997047305A1 (en)
ZA (1) ZA975160B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
DE10220230A1 (en) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Use of Rotigotine to treat restless leg syndrome
US8343538B2 (en) 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
DE102005034498A1 (en) * 2005-07-20 2007-01-25 Grünenthal GmbH Oral contraception with Trimegeston
US8217024B2 (en) 2005-12-27 2012-07-10 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
US8491927B2 (en) 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
US10821297B2 (en) * 2016-09-30 2020-11-03 Johnson & Johnson Consumer Inc. Kit and method for topical delivery of benefits
JP6982960B2 (en) * 2017-02-07 2021-12-17 リンテック株式会社 Packaging and packaging

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (en) * 1978-07-13 1980-02-08 Roussel Uclaf NOVEL 3,20-DIOXO 4,9-DIENE 21-HYDROXYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
DE3714140A1 (en) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts ACTIVE SUBSTANCE PLASTER FOR THE CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES TO THE SKIN, ITS USE AND METHOD FOR THE CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES TO THE SKIN
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel

Also Published As

Publication number Publication date
DE69731883T2 (en) 2005-12-22
AU739141B2 (en) 2001-10-04
CN1227492A (en) 1999-09-01
JP2000511921A (en) 2000-09-12
CN1119150C (en) 2003-08-27
EP0904086B1 (en) 2004-12-08
AR008229A1 (en) 1999-12-29
PL330597A1 (en) 1999-05-24
RU2209090C2 (en) 2003-07-27
CZ295350B6 (en) 2005-07-13
CA2257913A1 (en) 1997-12-18
AU3266197A (en) 1998-01-07
NO320999B1 (en) 2006-02-27
TR199802577T2 (en) 1999-03-22
NO985807D0 (en) 1998-12-11
EP0904086A1 (en) 1999-03-31
PL189361B1 (en) 2005-07-29
ES2235236T3 (en) 2005-07-01
WO1997047305A1 (en) 1997-12-18
DE69731883D1 (en) 2005-01-13
CZ410898A3 (en) 1999-09-15
FR2749514A1 (en) 1997-12-12
ATE284215T1 (en) 2004-12-15
BR9715082A (en) 2003-07-15
FR2749514B1 (en) 1998-08-07
ZA975160B (en) 1998-06-11
TWI228999B (en) 2005-03-11

Similar Documents

Publication Publication Date Title
DK1538160T3 (en) Substituted isoquinoline-3-carboxylic acid amides, their preparation and their use as a drug
NO991815D0 (en) Oxadiazoles, processes for their preparation and their use as drugs
NO975513L (en) 3-hydroxypyridine-2-carboxylic acid amide, preparation and use as a drug
NO933434D0 (en) PIPERIDE INGREDIENTS, THEIR PREPARATION AND USE
NO20004353L (en) New pyridazine derivatives and drugs containing these as active ingredients
EE200000065A (en) Aerosol formulations containing biologically active macromolecules and water, and method for their preparation
DK0854880T3 (en) Derivatives of 5-O-desosaminyl-6-O-methyl-erythronolide A, process for their preparation and their use in the preparation of biologically active products
DK267489D0 (en) 1-DEOXY-NOJIRIMYCIN DERIVATIVES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
EE9600172A (en) Purin-6-one derivatives, their preparation method, use in the preparation of medicaments and medicaments
DK0770059T3 (en) Substituted benzamidines, their preparation and their use as drugs
NO981522D0 (en) Amino acid derivatives, their preparation and use as endothelin antagonists
NO992408D0 (en) Process for Low Waste Preparation of Sliced Formulas Containing Active Ingredients, and Transdermal Therapeutic Systems Containing the Same
DK146786A (en) 4'-DEMETHYL-4-EPIPODOPHYLLOTOXIN DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICALS, ISAAE AS ANTITUMUM AGENTS
NO975020D0 (en) Azacycloalkane derivatives, their preparation and their use in therapy
NO985807D0 (en) Transdermal systems containing 2 active ingredients in separate sections, their preparation process and their use as a drug
FI951631L (en) Substituted kynurenines, method for their preparation and their use as medicaments
NO951418D0 (en) Peptide derivatives, their preparation and use as therapeutics
NO20001288L (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oils, process for their preparation and use as medicaments
DK60893D0 (en) PIPERIDE INGREDIENTS, THEIR PREPARATION AND USE
NO933435D0 (en) PIPERIDE INGREDIENTS, THEIR PREPARATION AND USE
NO974057D0 (en) Bisyclic tachykinin antagonists, their preparation and their use in pharmaceutical composition
DK0763535T3 (en) Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as central nervous system active compounds
NO900926L (en) SUBSTITUTED (QUINOLIN-2-YL-METOXY) PHENYL-N, N'-SULPHONYLURINE INGREDIENTS, THEIR PREPARATION AND USE IN PHARMACEUTICALS.
DK619989D0 (en) DIPEPTIDE DERIVATIVES, THEIR PREPARATION AND USE AS PHARMACEUTICALS
DK489889A (en) DIHYDROPYRIDINAMIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS